Neurobo Pharmaceuticals
13F holders, Q4 2024 (December 31)1holders
$0.00avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Neurobo Pharmaceuticals in their 13F filings. The largest holder was Financial Gravity Companies, Inc. ($0).
- Company
- Neurobo Pharmaceuticals
- CUSIP
- 641CVR014
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Financial Gravity Companies, Inc. | 0.00% | New | 915 | $0 |
"% of holder's portfolio" is NEUROBO PHARMACEUTICALS's weight in each manager's 13F, not the share of Neurobo Pharmaceuticals the manager owns.